Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structural and functional complementation of an inactive Bcl-2 mutant by Bax truncation

S Ottilie1, J L Diaz, J Chang

  • 1IDUN Pharmaceuticals, Inc., La Jolla, California 92037, USA. sottilie@idun.com

The Journal of Biological Chemistry
|July 4, 1997
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Silencing of Jagged1 inhibits cell growth and invasion in colorectal cancer.

Cell death & disease·2014
Same author

Final results from a randomized phase 3 study of FOLFIRI {+/-} panitumumab for second-line treatment of metastatic colorectal cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2013
Same author

trans-2-Nonenal insect repellent, insecticide, and flavor compound in carrot roots, cell suspensions, and "hairy" root cultures.

Journal of chemical ecology·2013
Same author

Volatiles identified from five stages of embryo development separated from a heterogeneous suspension culture of Daucus carota.

Plant cell reports·2013
Same author

Introducing the GRACEnet/REAP Data Contribution, Discovery, and Retrieval System.

Journal of environmental quality·2013
Same author

The role of the breast radiologist in evaluation of breast incidentalomas detected on 18-fludeoxyglucose positron emission tomography/CT.

The British journal of radiology·2013

Inactive Bcl-2 and Bcl-xL mutants bind Bax BH3 domains, revealing conformational constraints regulate protein interactions. This binding can block apoptosis, demonstrating a new mechanism for cell protection.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Proteins in the B-cell lymphoma 2 (Bcl-2) family control programmed cell death.
  • Death-inhibiting proteins Bcl-2 and Bcl-xL bind to the death-promoting protein Bax.
  • Mutations in Bcl-2 and Bcl-xL can abolish their biological activity and Bax binding.

Purpose of the Study:

  • To investigate the structural basis of heterodimer formation between Bcl-2 family proteins.
  • To identify Bax mutants that can bind to inactive Bcl-2 and Bcl-xL mutants.
  • To understand how conformational changes in Bax affect its interactions with other Bcl-2 family members.

Main Methods:

  • Yeast two-hybrid assay to screen for Bax mutants.
  • Site-directed mutagenesis of Bcl-2 and Bcl-xL proteins.

Related Experiment Videos

  • Analysis of protein-protein interactions and apoptosis induction.

    • Main Results:

    • Inactive Bcl-2(G145A) and Bcl-xL(G138A) mutants bind to C-terminally truncated Bax molecules containing the BH3 domain.
    • Full-length Bax mutants that bind to inactive Bcl-2/Bcl-xL were identified, indicating the BH3 domain is critical for binding.
    • Inactive Bcl-2(G145A) blocked apoptosis induced by truncated Bax but not wild-type Bax.

    Conclusions:

    • Conformational constraints in full-length Bax regulate its binding to other Bcl-2 family members.
    • The BH3 domain of Bax is essential for binding to inactive Bcl-2 and Bcl-xL.
    • Direct binding to pro-apoptotic proteins can mediate cell protection, offering a novel therapeutic strategy.